Investor Alert

New York Markets Close in:

Nov. 3, 2021, 1:57 p.m. EDT

Global Cancer/Tumour Profiling Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2021-2026 | EMR Inc.

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Illumina Inc. (ILMN)

or Cancel Already have a watchlist? Log In

Nov 03, 2021 (AB Digital via COMTEX) -- The new report by Expert Market Research titled, ‘Global Cancer/Tumour Profiling Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global cancer/tumour profiling market, assessing the market based on its segments like by types of cancer, types of biosensors, technology, research application, clinical applications and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Note 1: For a snapshot of the primary and secondary data of the market (2016-2026), along with business strategies and detailed market segmentation, please click on the request sample report. The sample report shall be delivered to you within 24 hours.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/cancer-tumor-profiling-market/requestsample

The key highlights of the report include:

Market Overview (2016-2026)

  • Historical Market Size (2020): USD7.8 Billion

  • Forecast CAGR (2021-2026): 10.2%

  • Forecast Market Size (2026): USD 14Billion

The growth of the cancer/tumour profiling market is being driven by a rise in cancer research and funding programs, as well as technical advances in profiling technology. Furthermore, the rising demand for personalized medicine and point-of-care diagnostics is projected to provide substantial growth opportunities for market participants during the forecast term.

Industry Definition and Major Segments

Cancer/tumour profiling is used to obtain insight into a patient’s cancer profile and make genomic changes that enable doctors to direct a patient to the best care option. As a result, profiling helps physicians to prevent potentially harmful treatments, reducing errors and trial procedures. Technological advances have aided the growth and application of tumour profiling tools, which can classify core characteristics of a patient’s cancer at an early stage and thereby direct the therapy selection for that patient. Personalized medicine has entered modern clinical practice and is transforming the way certain illnesses are diagnosed, categorized, and treated. It has become a central field of study in the healthcare sector.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/cancer-tumor-profiling-market

The types of cancer can be divided into:

  • Breast Cancer

  • Lung Cancer

  • Colorectal Cancer

  • Prostate Cancer

  • Melanoma

  • Others

The types of biosensors can be segmented into:

  • Genetic Biomarkers

  • Protein Biomarkers

  • Others

The cancer/tumour profiling market can be broadly categorised based on technology into:

  • Immunoassays

  • Next-Generation Sequencing

  • Polymerase Chain Reaction

  • In Situ Hybridization

  • Microarrays

  • Mass Spectrometry

  • Others

It finds its uses in the research and clinical applications.

Research applications can be further divided into:

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.